The Pat Summitt Foundation
Pat's Definite Dozen
The Pat Summitt Clinic
East Tennessee Foundation
Advisory Board & Staff
Information & Resources
Medical Advisory Council
Alzheimer's in the News
Join Pat’s Team
We Back Pat Games
SEC Win Challenge
Coordinate an Event
Join Our Mailing List
Salute for a Cure
Ways To Give
Medical Advisory Council
to view published research from our Medical Advisory Council.
The Pat Summitt Foundation has established a Medical Advisory Council that includes some of the nation’s leading experts in Alzheimer’s disease research.
Co-chaired by Dr. Ron Petersen and Dr. John Dougherty, the Medical Advisory Council serves in the following roles for The Pat Summitt Foundation:
Serves as the Foundation’s liaison to the medical and research community.
Informs the Foundation on medical and research developments in diagnosis, treatment, funding, and policy for Alzheimer’s disease on a regular basis.
Serves as voluntary spokespersons about medical and research developments on behalf of the Foundation.
Advises the Foundation on designing its
process for research and medical programs and partnerships.
The Pat Summitt Foundation Medical Advisory Council
John H. Dougherty, Jr., MD
Ronald C. Petersen,
Allan I. Levey, MD
William R. Shankle, MS, MD, FACP
Pierre N. Tariot, MD
Dr. John Dougherty
, Retired Medical Director of The Cole Neuroscience Center at The University of Tennessee Medical Center in Knoxville, Tennessee.
Dr. Dougherty is a recognized leader in the evaluation,
and management of patients with memory loss. He spent more than 30 years in
, with a focus on Alzheimer’s disease and dementia.
In 2004, he co-founded Medical Interactive Education (Medinteract), a health education organization that provides the latest research and information about brain wellness as well as computerized cognitive screening.
Dr. Dougherty served as co-director of the Brain and Spine Institute at the UT Medical Center as well as Assistant Professor of Medicine in
at UT. Throughout his career, he published numerous articles on dementia and Alzheimer’s disease.
Dr. Ronald Petersen,
Director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging in Rochester, Minnesota.
Dr. Petersen received a Ph.D. in Experimental Psychology from the University of Minnesota and graduated from Mayo Medical School in 1980. He completed an internship in Medicine at Stanford University Medical Center and returned to the Mayo Clinic to complete a residency in Neurology. That was followed by a fellowship in Behavioral Neurology at Harvard University Medical School/Beth Israel Hospital in Boston, Massachusetts. Dr. Petersen joined the staff of the Mayo Clinic in 1986 and rose through the ranks to become a Professor of Neurology in 1996. In 2000 he was named the Cora Kanow Professor of Alzheimer’s Disease Research and Mayo Clinic Distinguished Investigator in 2011.
He is currently the Director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging and has authored over 550 peer-reviewed articles on memory disorders, aging, and Alzheimer’s disease. He has edited five books, Memory Disorders, Mayo Clinic on Alzheimer’s Disease, Mild Cognitive Impairment: Aging to Alzheimer’s Disease, Mayo Clinic Guide to Alzheimer’s Disease and Mayo Clinic on Alzheimer’s Disease (2013).
Dr. Petersen is one of the recipients of the 2004 MetLife Award for Medical Research in Alzheimer’s Disease and the 2005 Potamkin Prize for Research in Picks, Alzheimer’s and Related Disorders of the American Academy of Neurology. Dr. Petersen also received the inaugural Ronald and Nancy Reagan Research Institute Award in 2004 from the Alzheimer’s Association and the inaugural Leon Thal Prize of the Lou Ruvo Brain Institute in 2007. In 2012 he received the Khachaturian Award of the Alzheimer’s Association and the Henry Wisniewski Lifetime Achievement Award in 2013. In 2011 he was appointed by the Secretary of Health and Human Services, Kathleen Sebelius, to serve as the Chair of the Advisory Committee on Research, Care and Services for the National Alzheimer’s Project Act.
Dr. Allan Levey,
Betty Gage Holland Chair, is Professor and Chair of the Dept of Neurology, and Director of Emory Alzheimer's Disease Research Center at the Emory University School of Medicine in Atlanta, Georgia.
Dr. Levey has secondary faculty appointments in the Departments of Pharmacology and Psychiatry and Behavioral Sciences at Emory.
Dr. Levey received a BS from University of Michigan and an MD and
(Immunology) from the University of Chicago. He then trained in Neurology at Johns Hopkins, molecular biology at the National Institutes of Health, and then joined the Johns Hopkins faculty in the Departments of Neurology & Pathology. Dr. Levey has been at Emory University since 1991, where he has held a number of positions, including Director of Graduate Studies for the Neuroscience
Program, Founding Director of the Emory Center for Neurodegenerative Disease, and Director of the Emory MD/
Dr. Levey is a neurologist and neuroscientist internationally recognized for his work in neurodegenerative disease. He has more than 270 research publications. His work has contributed to understanding the brain systems and mechanisms involved in neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases and in identifying molecular targets for new therapeutic strategies. He has received several awards including the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association, the Heikkila Research Scholar Award from the National Parkinson Foundation, the Health Advancement Research Award from Community Health Charities, the Team Hope Award for Medical Leadership from the Huntington’s Disease Society of America, and he was inducted into the Johns Hopkins Society of Scholars. Dr. Levey was also named an ISI Highly Cited Researcher in the field of Neuroscience and has consistently been listed among one of the Best Doctors in America.
Dr. William Shankle,
Medical Director of Shankle Clinic and the Judy and Richard Voltmer Chair in Memory and Cognitive Disorders at Hoag Neurosciences Institute, and is Associate Researcher with the Cognitive Science Department at the University of California Irvine and is Chief Medical Officer, Medical Care Corporation in Newport Beach, California.
Dr. Shankle is a board certified neurologist, specializes in the diagnosis,
and management of Alzheimer's disease and related disorders (ADRD). He is also a biostatistician, specializes in analysis of various types of clinical data.
He currently holds, at Hoag Neurosciences Institute, the Judy and Richard Voltmer endowed
in Memory and Cognitive Disorders Program, and also services as a director of Orange County Vital Brain Aging Program. In addition, he maintains his academic career at the Department of Cognitive Sciences at the University of California, Irvine. He also holds additional responsibilities as a member of the grant review committee for the National Alzheimer's Association, and as a journal reviewer for many ADRD related journals, and a chief medical
of Medical Care Corporation.
He served, for 10 years, as a clinical director at the Alzheimer's Research Clinic at the University of California, Irvine, since 1987. Following that endeavor, he initiated a
ADRD program, Shankle Clinic, in 1997, where he still continues to deliver his medical knowledge and share his personal experiences as a caregiver to more patients and families.
Dr. Shankle received his bachelor’s degree in Biology from Stanford University and his MD from Brown University. He also received his master’s degrees in Biostatistics at the University of Southern California with postgraduate studies at Harvard. He was trained as an internist at Cook County Hospital, and finally, as a neurologist at LA County/USC Medical Center. He is a recipient of Alzheimer’s Association’s Zenith Pioneer Award.
, Director of the Banner Alzheimer’s Institute, Co-Director of the Alzheimer’s Prevention Initiative and Research Professor of Psychiatry at the University of Arizona College of Medicine in Phoenix, Arizona.
Dr. Tariot is a Phi Beta Kappa graduate of Amherst College who attended the University of Rochester School of Medicine. He completed residencies in Internal Medicine and Psychiatry at the University of Wisconsin in Madison, Wisconsin, and is Board Certified in both specialties, with added qualifications in geriatrics. He served as a Medical Staff Fellow and then Senior Staff Fellow at the Intramural Research Program of the National Institute of Mental Health. In 1986, he joined the faculty of the University of Rochester Medical Center, achieving the rank of Professor of Psychiatry, Medicine, Neurology, and Aging and Developmental Biology. He served as Director of the Memory Disorders Clinic, Director of Psychiatry at Monroe Community Hospital, and Director of the University of Rochester component of the NIA-funded Alzheimer’s Disease Cooperative Study. Since 2006, he has been at the Banner Alzheimer’s Institute, where he serves as Director. Together with his colleague and friend, Eric Reiman, he serves as co-director of the Alzheimer’s Prevention Initiative, an NIH-funded international program to study experimental therapies that may delay or even prevent the symptoms of Alzheimer’s in people at high imminent risk. He has an appointment as Research Professor of Psychiatry at the University of Arizona College of Medicine. He is a member of the American College of Neuropsychopharmacology. Dr. Tariot has investigated, and lectured extensively on, multiple aspects of diagnosis and therapy for dementia and Alzheimer’s disease, and recognition and management of behavioral disturbances in dementia. He has published over 240 papers on these topics. He has earned several awards for his research, including the American Geriatrics Society New Investigator Award for Neuroscience, an NIMH Geriatric Mental Health Academic Award, 2005 UCLA Turken Award, and Fellowship in the Gerontological Society of America. Dr. Tariot’s research affiliations include the National Institute of Mental Health, the New York State Department of Health, Arizona Department of Health, the National Institute on Aging, the Institute for Mental Health Research, and the Alzheimer’s Association.
Together We Will Win!
Together We Will Win!